• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二乘二析因试验设计的非析因分析

Non-factorial analyses of two-by-two factorial trial designs.

作者信息

Korn Edward L, Freidlin Boris

机构信息

Biometric Research Program, National Cancer Institute, Bethesda, MD, USA

Biometric Research Program, National Cancer Institute, Bethesda, MD, USA.

出版信息

Clin Trials. 2016 Dec;13(6):651-659. doi: 10.1177/1740774516659472. Epub 2016 Jul 19.

DOI:10.1177/1740774516659472
PMID:27439306
Abstract

BACKGROUND/AIMS: Factorial analyses of 2 × 2 trial designs are known to be problematic unless one can be sure that there is no interaction between the treatments (A and B). Instead, we consider non-factorial analyses of a factorial trial design that addresses clinically relevant questions of interest without any assumptions on the interaction. Primary questions of interest are as follows: (1) is A better than the control treatment C, (2) is B better than C, (3) is the combination of A and B (AB) better than C, and (4) is AB better than A, B, and C.

METHODS

A simple three-step procedure that tests the first three primary questions of interest using a Bonferroni adjustment at the first step is proposed. A Hochberg procedure on the four primary questions is also considered. The two procedures are evaluated and compared in limited simulations. Published results from three completed trials with factorial designs are re-evaluated using the two procedures.

RESULTS

Both suggested procedures (that answer multiple questions) require a 50%-60% increase in per arm sample size over a two-arm design asking a single question. The simulations suggest a slight advantage to the three-step procedure in terms of power (for the primary and secondary questions). The proposed procedures would have formally addressed the questions arising in the highlighted published trials arguably more simply than the pre-specified factorial analyses used.

CONCLUSION

Factorial trial designs are an efficient way to evaluate two treatments, alone and in combination. In situations where a statistical interaction between the treatment effects cannot be assumed to be 0, simple non-factorial analyses are possible that directly assess the questions of interest without the zero interaction assumption.

摘要

背景/目的:已知2×2试验设计的析因分析存在问题,除非能够确定各治疗方法(A和B)之间不存在交互作用。相反,我们考虑对析因试验设计进行非析因分析,该分析无需对交互作用做任何假设就能解决临床上相关的感兴趣问题。感兴趣的主要问题如下:(1)A是否优于对照治疗C,(2)B是否优于C,(3)A与B的联合治疗(AB)是否优于C,以及(4)AB是否优于A、B和C。

方法

提出了一个简单的三步程序,第一步使用Bonferroni校正来检验前三个感兴趣的主要问题。还考虑了针对这四个主要问题的Hochberg程序。在有限的模拟中对这两个程序进行了评估和比较。使用这两个程序对三项已完成的析因设计试验的已发表结果进行了重新评估。

结果

两种建议的程序(回答多个问题)与回答单个问题的双臂设计相比,每个治疗组的样本量都需要增加50%-60%。模拟结果表明,在检验效能方面(针对主要和次要问题),三步程序略有优势。所提出的程序可以比使用预先指定的析因分析更简单地正式解决突出显示的已发表试验中出现的问题。

结论

析因试验设计是单独和联合评估两种治疗方法的有效方式。在不能假设治疗效果之间的统计交互作用为0的情况下,可以进行简单的非析因分析,直接评估感兴趣的问题,而无需零交互作用假设。

相似文献

1
Non-factorial analyses of two-by-two factorial trial designs.二乘二析因试验设计的非析因分析
Clin Trials. 2016 Dec;13(6):651-659. doi: 10.1177/1740774516659472. Epub 2016 Jul 19.
2
Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.用于多种治疗的临床试验的析因设计与多臂多阶段设计
Stat Med. 2017 Feb 20;36(4):563-580. doi: 10.1002/sim.7159. Epub 2016 Nov 2.
3
Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial.分配随机化:一种实用的分数析因设计,用于在临床试验中筛选或评估多种同时进行的干预措施。
BMC Med Res Methodol. 2024 Mar 11;24(1):64. doi: 10.1186/s12874-024-02191-9.
4
Joint testing of overall and simple effects for the two-by-two factorial trial design.两因素析因试验设计的总效应和简单效应联合检验。
Clin Trials. 2021 Oct;18(5):521-528. doi: 10.1177/17407745211014493. Epub 2021 Aug 18.
5
Factorial designs: an overview with applications to orthodontic clinical trials.析因设计:正畸临床试验应用概述
Eur J Orthod. 2014 Jun;36(3):314-20. doi: 10.1093/ejo/cjt054. Epub 2013 Jul 24.
6
Factorial design considerations.析因设计考量因素。
J Clin Oncol. 2002 Aug 15;20(16):3424-30. doi: 10.1200/JCO.2002.03.003.
7
When should factorial designs be used for late-phase randomised controlled trials?何时应使用析因设计进行后期随机对照试验?
Clin Trials. 2024 Apr;21(2):162-170. doi: 10.1177/17407745231206261. Epub 2023 Oct 31.
8
Simultaneous inference on treatment effects in survival studies with factorial designs.析因设计生存研究中治疗效果的同时推断。
Biometrics. 2016 Dec;72(4):1078-1085. doi: 10.1111/biom.12507. Epub 2016 Mar 17.
9
Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?二乘二析因癌症治疗试验:是否充分关注了可能的相互作用?
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx146.
10
Design, analysis and presentation of factorial randomised controlled trials.析因随机对照试验的设计、分析与报告
BMC Med Res Methodol. 2003 Nov 24;3:26. doi: 10.1186/1471-2288-3-26.

引用本文的文献

1
Effectiveness of the Positive deviance and parent facilitator training strategies on the nutritional status of children and youth with cerebral palsy: A quasi-randomised trial with a factorial design.积极偏差与家长促进者培训策略对脑瘫儿童和青少年营养状况的有效性:一项析因设计的半随机试验。
PLOS Glob Public Health. 2025 Aug 19;5(8):e0005027. doi: 10.1371/journal.pgph.0005027. eCollection 2025.
2
Guidance for protocol content and reporting of factorial randomised trials: explanation and elaboration of the CONSORT 2010 and SPIRIT 2013 extensions.析因随机试验的方案内容与报告指南:CONSORT 2010和SPIRIT 2013扩展版的解释与阐述
BMJ. 2025 Feb 4;388:e080785. doi: 10.1136/bmj-2024-080785.
3
Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
《析因随机临床试验方案的共识声明:SPIRIT 2013 声明的扩展》。
JAMA Netw Open. 2023 Dec 1;6(12):e2346121. doi: 10.1001/jamanetworkopen.2023.46121.
4
Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.报告析因随机试验:CONSORT 2010 声明的扩展。
JAMA. 2023 Dec 5;330(21):2106-2114. doi: 10.1001/jama.2023.19793.
5
When should factorial designs be used for late-phase randomised controlled trials?何时应使用析因设计进行后期随机对照试验?
Clin Trials. 2024 Apr;21(2):162-170. doi: 10.1177/17407745231206261. Epub 2023 Oct 31.
6
Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: a randomized controlled trial {1}.运动训练和 NR 补充剂改善青少年和年轻成年造血细胞移植幸存者的肌肉质量和健康状况:一项随机对照试验{1}。
BMC Cancer. 2022 Jul 19;22(1):795. doi: 10.1186/s12885-022-09845-1.
7
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.结合析因和多臂多阶段平台设计来有效地评估多种干预措施。
Clin Trials. 2022 Aug;19(4):432-441. doi: 10.1177/17407745221093577. Epub 2022 May 17.
8
Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.非维生素 K 拮抗剂口服抗凝剂双联抗栓治疗在经皮冠状动脉介入治疗的心房颤动患者中的安全性和疗效:系统评价和荟萃分析。
J Am Heart Assoc. 2020 Aug 18;9(16):e017212. doi: 10.1161/JAHA.120.017212. Epub 2020 Aug 1.
9
Testing Behavior Change Techniques to Encourage Primary Care Physicians to Access Cancer Screening Audit and Feedback Reports: Protocol for a Factorial Randomized Experiment of Email Content.测试行为改变技术以鼓励初级保健医生查阅癌症筛查审计与反馈报告:电子邮件内容析因随机试验方案
JMIR Res Protoc. 2018 Feb 16;7(2):e11. doi: 10.2196/resprot.9090.
10
Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?二乘二析因癌症治疗试验:是否充分关注了可能的相互作用?
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx146.